CLDX Trading Analysis - 09/14/2026 12:02 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for CLDX include:

• CLDX announced a new partnership with a major pharmaceutical company to develop a novel cancer treatment.
• The company received FDA approval for its new drug application, which is expected to drive revenue growth.
• CLDX reported strong quarterly earnings, beating analyst estimates and driving stock price increases.

These headlines suggest that CLDX has significant catalysts for growth, including new partnerships, FDA approvals, and strong earnings reports. This context may relate to the technical and sentiment data, potentially driving bullish trends.

Fundamental Analysis:

Based on the provided data, a fundamental analysis of CLDX is not feasible as specific fundamental data points such as revenue growth rate, profit margins, earnings per share (EPS), and P/E ratio are not provided.

Current Market Position:

CLDX is currently trading at $38.41. Recent price action shows a slight increase, with the stock reaching a high of $38.45 and a low of $37.27 on September 14.

Key support and resistance levels are:

• Support: $37.27 (recent low)
• Resistance: $38.45 (recent high)

Intraday momentum and trends from minute bars indicate a relatively stable price movement with a slight upward trend.

Technical Analysis:

SMA trends:

• 5-day SMA: $38.26
• 20-day SMA: $39.82
• 50-day SMA: $39.13

The stock is currently below its 20-day and 50-day SMAs, indicating a potential downtrend. The RSI (14) is at 37.44, suggesting that the stock may be oversold. The MACD is at -0.4, indicating a bearish signal.

Bollinger Bands:

• Middle: $39.82
• Upper: $42.34
• Lower: $37.29

The stock is currently near the lower Bollinger Band, which may indicate a potential bounce-back.

True Sentiment Analysis (Delta 40-60 Options):

The overall options flow sentiment is bullish, with a call dollar volume of $2,063,790 and a put dollar volume of $0. The call percentage is 100%, indicating strong bullish conviction.

Key Price Levels (observational only):

Support levels:

• $37.29 (lower Bollinger Band)
• $37.27 (recent low)

Resistance levels:

• $42.34 (upper Bollinger Band)
• $38.45 (recent high)

25-Day Price Forecast:

CLDX is projected for $37.50 to $40.50.

Based on current technical trends, momentum, and indicators, the stock price may fluctuate within this range over the next 25 days. The projection considers the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast of $37.50 to $40.50, the following defined risk strategies are recommended:

1. Bull Call Spread: Buy the $38.0 call and sell the $40.0 call. This strategy benefits from a potential price increase while limiting risk.
2. Bear Put Spread: Buy the $37.0 put and sell the $35.0 put. This strategy benefits from a potential price decrease while limiting risk.
3. Iron Condor: Sell the $38.0 call, buy the $40.0 call, sell the $37.0 put, and buy the $35.0 put. This strategy benefits from a stable price movement while limiting risk.

Risk Factors:

Technical warning signs or weaknesses:

• The stock is currently below its 20-day and 50-day SMAs.
• The MACD is indicating a bearish signal.

Sentiment divergences from price action:

• The options flow sentiment is bullish, while the technical indicators suggest a bearish trend.

Volatility and ATR considerations:

• The ATR is at 1.32, indicating moderate volatility.

Summary & Conviction Level:

Overall bias: Neutral.

Conviction level: Medium.

One-line trade idea: CLDX may experience a price fluctuation within the projected range of $37.50 to $40.50.